This is a working overview of angiogenesis, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-03-26 and is reviewed periodically as new material appears.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
| Property | Value | Notes |
|---|---|---|
| Main study model | Rodents, rats and mice | Underpins most of the published data |
| Common routes in studies | Subcutaneous, intraperitoneal, oral | Varies with the experimental design |
| Common analytical method | Reversed-phase HPLC, LC-MS | Used for identity and purity checks |
| Human evidence base | Small | Few trials reported, with limited findings |
| Regulatory status | Varies by jurisdiction | Not an approved medicine in most places |
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
== Medications == A variety of different sex-hormonal medications are used in feminizing hormone therapy for transgender women. These include estrogens to induce feminization and suppress testosterone levels; antiandrogens such as androgen receptor antagonists, antigonadotropins, GnRH modulators, and 5α-reductase inhibitors to further oppose the effects of androgens like testosterone; and progestogens for various possible though uncertain benefits. An estrogen in combination with an antiandrogen is the mainstay of feminizing hormone therapy for transgender women.
FC Lokomotive Leipzig was promoted to Regionalliga Nordost after finishing Oberliga sixth due to the reserve teams of FC Rot-Weiß Erfurt, Dynamo Dresden, and FC Carl Zeiss Jena being ineligible for promotion. Lokomotive finished in tenth place in the 2012–13 season but were relegated to Oberliga Nordost after finishing 15th in 2013–14. The club stayed in contention for promotion back up to the Regionalliga during the 2014–15 season, having hired former German international Mario Basler as director of sports in early 2015. In the final match of the season, Lok supporters stormed the field after their club had fallen behind 2–0, forcing the match to be abandoned and the club to finish outside of the promotion ranks. The club finished in first place in the southern group of the NOFV-Oberliga and returned to the Regionalliga Nordost for the 2016–17 season.
=== From underground brine reservoirs === In the Salar de Atacama in the Atacama Desert of Northern Chile, lithium carbonate and lithium hydroxide are produced from brine. The process pumps lithium rich brine from below ground into shallow pans for evaporation. The brine contains many different dissolved ions, and as their concentration increases, salts precipitate out of solution and sink. The remaining supernatant liquid is used for the next step. The sequence of pans may vary depending on the concentration of ions in a particular source of brine. In the first pan, halite (sodium chloride or common salt) crystallizes. This has little economic value and is discarded. The supernatant, with ever increasing concentration of dissolved solids, is transferred successively to the sylvinite (sodium potassium chloride) pan, the carnallite (potassium magnesium chloride) pan and finally a pan designed to maximize the concentration of lithium chloride. The process takes about 15 months. The concentrate (30-35% lithium chloride solution) is trucked to Salar del Carmen. There, boron and magnesium are removed (typically residual boron is removed by solvent extraction and/or ion exchange and magnesium by raising the pH above 10 with sodium hydroxide) then in the final step, by addition of sodium carbonate, the desired lithium carbonate is precipitated out, separated, and processed. Some of the by-products from the evaporation process may also have economic value. There is considerable attention to the use of water in this water poor region.
We would be more likely to communicate with highly advanced civilizations that would know and use the laws of physics to a degree that we would not yet be able to understand. Kardashev asserted that "this last point should be taken into account in the research programs of extraterrestrial civilizations" and concluded that it is very likely that our present state is only one of the stages through which every civilization passes during its evolution.
After UMNO lost power at the 2018 Malaysian general election, Malaysia's ranking increased by 9 places in the 2019 Democracy Index to 43rd compared to the previous year; the country is classified as a 'flawed democracy'. Malaysia's ranking in the 2020 Press Freedom Index increased by 22 places to 101st compared to the previous year, making it one of two countries in Southeast Asia without a 'Difficult situation' or 'Very Serious situation' with regards to press freedom. However, it fell 18 places the following year due to the policies of the PN government. Malaysia is marked at 48th and 62nd place according to the 2021 Corruption Perceptions Index, indicating above-average levels of corruption. Freedom House noted Malaysia as "partly free" in its 2018 survey. A lawsuit filed by the United States Department of Justice alleged that at least $3.5 billion involving former prime minister Najib Razak had been stolen from Malaysia's 1MDB state-owned fund, known as the 1Malaysia Development Berhad scandal. As of 2025, it is ranked 13th on the Global Peace Index.
Sources: en.wikipedia.org
It is known also as simpler's joy or holy herb, or more ambiguously as mosquito plant or wild hyssop. The common name blue vervain is also sometimes used, but also refers to V. hastata. Being the only member of its genus in much of its range, it is also simply known as vervain locally. The common names of V. officinalis in many Central and Eastern European languages often associate it with iron, for example:
N-Methylethanolamine is an alkanolamine with the formula CH3NHCH2CH2OH. It is flammable, corrosive, colorless, viscous liquid. It is an intermediate in the biosynthesis of choline. With both an amine and a hydroxyl functional groups, it is a useful intermediate in the chemical synthesis of various products including polymers and pharmaceuticals. It is also used as a solvent, for example in the processing of natural gas, where it is used together with its analogs ethanolamine and dimethylethanolamine.
== History == The code name "Looking Glass" came from the aircraft's ability to "mirror" the command and control functions of the underground command post at the U.S. Air Force's Strategic Air Command (SAC) headquarters at Offutt AFB, Nebraska.
== Sources == Nucleosides can be produced from nucleotides de novo, particularly in the liver, but they are more abundantly supplied via ingestion and digestion of nucleic acids in the diet, whereby nucleotidases break down nucleotides (such as the thymidine monophosphate) into nucleosides (such as thymidine) and phosphate. The nucleosides, in turn, are subsequently broken down in the lumen of the digestive system by nucleosidases into nucleobases and ribose or deoxyribose. In addition, nucleotides can be broken down inside the cell into nitrogenous bases, and ribose-1-phosphate or deoxyribose-1-phosphate.
== Applications == Bonded leather can be found in furniture, bookbinding, and various fashion accessories. Products that are commonly constructed with different varieties of bonded leather include book covers, cases and covers for personal electronics, shoe components, textile and accessory linings, portfolios and briefcases, handbags, belts, chairs, and sofas. A more fragile paper-backed bonded leather is typically used to cover books such as diaries and Bibles, and various types of desk accessories. These bonded leathers might contain a smaller proportion of leather than those used in the furniture industry, and have some leather exposed in the product's surface, producing the characteristic odor associated with leather. These same applications can alternately use artificial leather constructed in a similar appearance to bonded leather.
Sources: en.wikipedia.org
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.
They are best described as working hypotheses. Supporting data come mainly from cell cultures and animal tissue, using markers such as growth factors and inflammatory signals. Confirmatory human studies have not been reported.
Status depends on the country. In some places it is treated as a research chemical available without a prescription, while elsewhere it falls under prescription or controlled rules. It holds no general marketing approval as a therapeutic product.
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.